FDA NDC Directory · JSON-LD · Markdown

Nevirapine

NDC 0378-4890 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic namenevirapine
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205651
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsNEVIRAPINE (400 mg/1)
Marketing started20141029
Package count1

External sources

Source: openFDA. Public-domain (CC0).